GYNAECOLOGICAL CANCERS
- Home
- GYNAECOLOGICAL CANCERS
gynaecological cancer screening
Gynecological cancers include:
-
Cancer of Body of Uterus
-
Cancer of Cervix
-
Cancer of Ovaries
-
Cancer of Fallopian Tube
-
Cancer of Breast
Cancer Screening is crucial for:
-
Early Detection of Cancer
-
To Improve the Treatment Success Rate
-
To Prevent Advance Cancer
-
Improved Survival Rate
-
Personalized Care Plans
-
Reduced Side Effects of the Treatment
-
Emphasis on Preventive Measures
-
Reducing the Overall Cost of Cancer Treatment
Vaccination for cervical cancer
Cervical cancer is mainly caused by HPV which is the second most common cancer in Indian women. The mortality rate of cervical cancer in India is more than 70%. This virus is responsible for a spectrum of diseases, including cervical cancer, which ranks as the second most common cancer in Indian women. The impact of HPV extends beyond cervical cancer in women (also causes vulvar, vaginal, anal, and oropharyngeal cancers), and also affects men with consequences ranging from genital warts to various types of male cancers (oropharyngeal, anal, and penile cancers). The burden of these diseases is a reminder of the urgency of understanding HPV and preventing its spread.
Special Situations HPV vaccine can be safely co-administered with other age-appropriate vaccines.
-
It is not recommended for use in pregnancy. If the patient conceives after the first dose, it is advisable to give further doses after pregnancy.
-
If inadvertent vaccination during pregnancy, no need for the medical termination of pregnancy.
-
Lactating women can receive the HPV vaccine. Available evidence does not indicate an increased risk of adverse events in either the mothers or their babies after the administration of the HPV vaccine to lactating mothers.
-
Sexual assault survivors should be given age-appropriate HPV vaccination, with the first dose at the time of initial examination.
-
Women with abnormal Pap/Positive HPV test/previous HPV lesions: Can be vaccinated if they desire; however, they should be counseled that it is not a therapeutic vaccine and will not treat existing pathology and there is reduced efficacy in older women.
-
HPV vaccination is a primary prevention intervention and does not eliminate the need for screening, since the existing vaccines do not protect against all high-risk HPV. The screening for cervical cancer should be done as per the guidelines.
